Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yeqing Dong

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Disease Markers|October 17, 2022
HSPA1A, HSPA2, and HSPA8 Are Potential Molecular Biomarkers for Prognosis among HSP70 Family in Alzheimer's DiseaseYeqing Dong, Tongxin Li, Zhonghui Ma, et al.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi|May 6, 2022
[An optical parameter imaging system with profile information fusion]Tongxin Li, Yeqing Dong, Ming Liu, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 23, 2025
The sex-specific relationship of ghrelin and cognition in Chinese han first-episode drug-naive major depressive disorderChuhao Zhang, Yuan Liu, Ying Gao, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 9, 2026
Cytokines and cognitive function in first-episode drug-naïve MDD: an inflammation panel perspectiveYeqing Dong, Chuhao Zhang, Bin Zhang, et al.
Psychoneuroendocrinology|November 27, 2025
Plasma biomarkers in drug-naïve schizophrenia with severe cognitive impairment via targeted metabolomicsYeqing Dong, Shuo Wang, Yuying Qiu, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 28, 2024
Immunoinflammatory features and cognitive function in treatment-resistant schizophrenia: unraveling distinct patterns in clozapine-resistant patientsYanzhe Li, Minghuan Zhu, Yeqing Dong, et al.
Schizophrenia (Heidelberg, Germany)|April 16, 2024
Association of cytokines levels, psychopathology and cognition among CR-TRS patients with metabolic syndromeYeqing Dong, Minghuan Zhu, Yanzhe Li, et al.
BMC Psychiatry|August 6, 2025
The multiomics landscape of plasma exosomes in first-episode drug-naïve of schizophreniaYeqing Dong, Shuo Wang, Meijuan Li, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 27, 2026
Static and dynamic alterations of local brain activity in schizophrenia and associations with clinical symptoms and cognitive functionShuzhe Wang, Peiwen Ren, Chenghao Lu, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 9, 2026
Baseline metabolic signature predicts cognitive improvement and longitudinal glycerophospholipid shifts track recovery in first-episode drug-naïve schizophreniaShuo Wang, Yueru Guo, Boxuan Zhou, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Disease Markers|October 17, 2022
HSPA1A, HSPA2, and HSPA8 Are Potential Molecular Biomarkers for Prognosis among HSP70 Family in Alzheimer's DiseaseYeqing Dong, Tongxin Li, Zhonghui Ma, et al.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi|May 6, 2022
[An optical parameter imaging system with profile information fusion]Tongxin Li, Yeqing Dong, Ming Liu, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 23, 2025
The sex-specific relationship of ghrelin and cognition in Chinese han first-episode drug-naive major depressive disorderChuhao Zhang, Yuan Liu, Ying Gao, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 9, 2026
Cytokines and cognitive function in first-episode drug-naïve MDD: an inflammation panel perspectiveYeqing Dong, Chuhao Zhang, Bin Zhang, et al.
Psychoneuroendocrinology|November 27, 2025
Plasma biomarkers in drug-naïve schizophrenia with severe cognitive impairment via targeted metabolomicsYeqing Dong, Shuo Wang, Yuying Qiu, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 28, 2024
Immunoinflammatory features and cognitive function in treatment-resistant schizophrenia: unraveling distinct patterns in clozapine-resistant patientsYanzhe Li, Minghuan Zhu, Yeqing Dong, et al.
Schizophrenia (Heidelberg, Germany)|April 16, 2024
Association of cytokines levels, psychopathology and cognition among CR-TRS patients with metabolic syndromeYeqing Dong, Minghuan Zhu, Yanzhe Li, et al.
BMC Psychiatry|August 6, 2025
The multiomics landscape of plasma exosomes in first-episode drug-naïve of schizophreniaYeqing Dong, Shuo Wang, Meijuan Li, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 27, 2026
Static and dynamic alterations of local brain activity in schizophrenia and associations with clinical symptoms and cognitive functionShuzhe Wang, Peiwen Ren, Chenghao Lu, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 9, 2026
Baseline metabolic signature predicts cognitive improvement and longitudinal glycerophospholipid shifts track recovery in first-episode drug-naïve schizophreniaShuo Wang, Yueru Guo, Boxuan Zhou, et al.
Pageof 4